ImmunoGen Inc., a Waltham biotechnology company, has appointed Dr. Charles Morris executive vice president and chief development officer, responsible for leading all aspects of product development. He reports to Daniel Junius, president and chief executive, the company said Monday. Morris had been executive vice president and chief medical officer at Allos Therapeutics Inc. ImmunoGen has three anticancer compounds in clinical testing.
Unlimited access to BostonGlobe.com for only 99 cents for the first 4 weeks.Sign up
Are you a home delivery subscriber?
Get FREE access as part of your print subscriptionStart Here
Contact us for help